BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/26/2024 2:07:30 PM | Browse: 351 | Download: 987
 |
Received |
|
2023-11-23 19:04 |
 |
Peer-Review Started |
|
2023-11-23 19:05 |
 |
First Decision by Editorial Office Director |
|
2024-01-05 05:47 |
 |
Return for Revision |
|
2024-01-05 05:47 |
 |
Revised |
|
2024-01-13 17:10 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-01-30 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-01-30 06:54 |
 |
Articles in Press |
|
2024-01-30 06:54 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-02-05 00:07 |
 |
Publish the Manuscript Online |
|
2024-02-26 13:28 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Immune signature of small bowel adenocarcinoma and the role of tumor microenvironment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Grigorios Christodoulidis, Marina Nektaria Kouliou and Konstantinos Eleftherios Koumarelas |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Grigorios Christodoulidis, PhD, Doctor, Doctor, Editor-in-Chief, Department of General Surgery, University Hospital of Larissa, Mezourlo, Larissa 41110, Greece. gregsurg09@gmail.com |
| Key Words |
Programmed cell death 1; Programmed cell death-ligand 1; Programmed death ligand; Small bowel adenocarcinoma; Tumor infiltrating lymphocytes; Tumor microenvironment; Microsatellite instability |
| Core Tip |
Small bowel adenocarcinoma (SBA) is an uncommon gastrointestinal tumor, accounting for fewer than 3% of all cases, even though it constitutes 95% of the gastrointestinal tract. SBA, which is mostly located in the duodenum, typically goes undetected for a long period of time, resulting to a late-stage discovery and a dismal prognosis. The immunological response, consisting of CD4+ and CD8+ T-lymphocytes, is critical in determining the prognosis. Programmed cell death 1/programmed cell death-ligand 1 (PD-L1) pathway, which is known to be involved in immune evasion in cancer, is implicated in SBA, with PD-L1 expression to a variety of prognostic consequences. The complicated interaction of immunological components, including as TILs and regulatory T cells, emphasizes the complexities of SBA. |
| Publish Date |
2024-02-26 13:28 |
| Citation |
Christodoulidis G, Kouliou MN, Koumarelas KE. Immune signature of small bowel adenocarcinoma and the role of tumor microenvironment. World J Gastroenterol 2024; 30(8): 794-798 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i8/794.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i8.794 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.